why choose us

First received: May 30, 2023

Clinical Trial: Solidarity/Tokomeza Ebola Trial

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Sudan Ebola Virus Vaccines

Study Type: INTERVENTIONAL


Official Title: A Phase I/II Randomized Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Sudan Ebolavirus Vaccines in Uganda

Brief Summary: The TokomezaPlus Ebola trial is a phase I/II double blind randomised clinical trial designed to assess the safety and immunogenicity of candidate SUDV vaccines in Uganda during the inter outbreak period.Uganda is prone to Ebola virus disease outbreaks especially those caused by the Ebola Sudan (SUDV) species.TokomezaPlus Ebola Vaccine trial protocol has two main components: a) Safety b) Immunogenicity and is designed to create a living protocol that will be used to study the safety and immunogenicity of…

Read more